Longyi blood glucose test system
Taiwan·Risk Class 2·Longsheng Pharmaceutical Co., Ltd.;; Taibo Technology Co., Ltd. five stock factory·Registered Jan 20, 2017 – Nov 28, 2020Cancelled- Analysis ID
- 63e6f84aa9c15a2221135eb828d00c52
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- DRAGON PHARMACEUTICAL CO., LTD.
- Intended Use
- Quantitatively measure the amount of glucose in the blood.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1345 Glucose Test System
- Import Information
- Domestic;; Contract manufacturing
- Registration Date
- Jan 20, 2017
- Expiry Date
- Nov 28, 2020
- Cancellation Date
- Jul 15, 2022
- Status
- Logged out
- Reason
- 未展延而逾期者
Top companies providing products similar to "Longyi blood glucose test system"
Recently registered similar products
Access comprehensive regulatory information for Longyi blood glucose test system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 63e6f84aa9c15a2221135eb828d00c52 and manufactured by Longsheng Pharmaceutical Co., Ltd.;; Taibo Technology Co., Ltd. five stock factory. The authorized representative in Taiwan is DRAGON PHARMACEUTICAL CO., LTD..
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Taibo Technology Co., Ltd. five-stock factory, and 2 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.